Futures
Hundreds of contracts settled in USDT or BTC
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Futures Kickoff
Get prepared for your futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to experience risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
Hims & Hers Health rose nearly 37% after hours, reports say Novo Nordisk plans to sell its weight loss drugs on the Hims platform
Hims & Hers Health stock rose nearly 37% after hours, reports say Novo Nordisk plans to sell its weight-loss drugs on Hims & Hers Health Inc.'s platform, ending a highly publicized dispute between the two companies that escalated to legal action last month. Novo Nordisk and Hims may announce a new partnership as early as next Monday. The two companies reached a similar agreement last year, but Novo Nordisk unilaterally terminated the deal after Hims refused to stop marketing and selling generic versions of the drugs.